If you've been hoping hormone therapy might help you feel like yourself again, that hope makes sense. For the right person, it's a real, effective treatment.
And knowing exactly what it's for is what helps you get the most out of it.
Because there's a version of hormone therapy making the rounds right now that we barely recognize.
In that version, it's a longevity protocol. An optimization stack. Something you take not because anything's wrong, but because you'd like to stay thirty-eight indefinitely. There are before-and-after photos. There's a lot of talk about "biological age." There's the quiet suggestion that one prescription can hold back time, and that anyone who says otherwise just hasn't caught up.
We understand the appeal. Wanting to feel like yourself again is real, and it's worth honoring.
We also want to be straight with you, because you deserve better than marketing.
Hormone therapy is a real, effective treatment. It isn't an anti-aging drug. And the difference between those two sentences matters more than almost anything else you'll read about it this year.
What hormone therapy is actually for
Menopausal hormone therapy is FDA-approved to treat a specific set of things: moderate to severe hot flashes and night sweats, which clinicians call vasomotor symptoms, and the changes to the vagina, vulva and urinary tract that come with dropping estrogen. Certain products are also approved to help prevent osteoporosis in women who are appropriate candidates.
That's the list.
And it's a good list. Those aren't cosmetic complaints. Vasomotor symptoms are the reason you might wake up four times a night, soaked, and then try to run a meeting at nine. Genitourinary symptoms are the reason intimacy can quietly disappear from a marriage without anyone saying why. Bone loss is the reason a fall at seventy-two can become a hip fracture. Treating those things well isn't a small ambition.
The Menopause Society's hormone therapy position statement says plainly that hormone therapy remains the most effective treatment available for vasomotor symptoms and for genitourinary syndrome of menopause, and that it has been shown to prevent bone loss and fracture.
The same statement is just as plain in the other direction: hormone therapy shouldn't be used to treat or prevent dementia.
Both halves are true at once. Good medicine usually looks like that.
Where the longevity story outruns the evidence
The U.S. Preventive Services Task Force has looked repeatedly at one specific question. Should postmenopausal people who don't have symptoms take hormones to prevent chronic disease? It has recommended against it, concluding the harms outweigh the benefits for that particular use.
Read that carefully, because it gets misquoted constantly in both directions.
The Task Force isn't saying hormone therapy is dangerous for women with symptoms. Its recommendation explicitly doesn't apply to people considering hormone therapy to manage menopausal symptoms. What it's saying is narrower and more useful: taking hormones as a general preventive measure, without symptoms, to ward off future disease, isn't supported by the evidence.
That's exactly what "anti-aging" framing asks hormone therapy to do.
The frame is the problem, not the medicine. Same prescription. Same molecule. But "I'm treating symptoms that are wrecking my sleep and my life" and "I'm taking this to slow down aging" are two different clinical decisions, with two different evidence bases and two different risk-benefit conversations.
Why the wrong frame costs you something real
This isn't a semantic argument. When hormone therapy gets sold as an anti-aging intervention, three things tend to go sideways.
You get set up for disappointment
If you start therapy expecting to feel twenty-eight, you'll almost certainly feel let down, even if the treatment is working exactly as intended. Hot flashes fading, sleep settling, brain fog lifting, sex no longer hurting: those are the wins. They're substantial. They're not the same as reversing aging, and measuring them against that standard makes real improvement look like failure.
The workup gets skipped
Anti-aging framing tends to travel with fast, frictionless prescribing. But the questions that actually protect you take a real conversation. Your personal and family history. Your cardiovascular risk. Your breast health. Whether you still have a uterus. What else could be driving these symptoms. Which route of delivery makes sense for your risk profile. Skipping that conversation isn't efficiency. It's just skipping.
Doses drift upward
When the goal is "optimization," there's no natural stopping point, because there's no symptom to resolve. When the goal is treating what's actually bothering you, there's a clear target, and a clear reason to reassess.
What careful care actually looks like
Current guidance has moved away from arbitrary rules like "the lowest possible dose for the shortest possible time" and toward something more honest: individualize. Use the best available evidence for you, weigh your benefits against your risks, and revisit the decision periodically rather than setting it and forgetting it.
The Menopause Society has also noted that for many women, there's no automatic expiration date at sixty-five. Continuing individualized therapy can be reasonable when the benefits still outweigh the risks for that particular person. That's not permission to stop paying attention. It's the opposite. The reassessment is the treatment plan.
Here's what that sounds like in the room. What's actually bothering you? How much is it costing you? What are we trying to change, and how will we know if it worked? What's your risk picture? When will we look at this again?
Not: what's your biological age.
When it's worth getting evaluated
If you're waking up drenched, snapping at people you love, foggy at work, dreading intimacy, or simply feeling like a stranger to yourself, those are symptoms. And symptoms are a good reason to get evaluated. You don't need to justify it with a longevity argument.
Feeling bad is enough.
And if you feel fine and you're considering hormones purely as insurance against the future, that's a conversation worth having too. An honest one, where someone tells you what the evidence does and doesn't support before you start.
Either way, the first step is the same: a real conversation with someone who'll look at your whole picture, not just sell you a protocol. We'd be glad to have it with you.
Schedule your free 30 minute consult.
This article is for education and isn't medical advice. Please see a qualified provider for an evaluation of your own symptoms and history.
Sources
- FDA, Menopause — consumers' guide to approved uses of menopausal hormone therapy https://www.fda.gov/consumers/womens-health-topics/menopause
- U.S. Preventive Services Task Force, Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/menopausal-hormone-therapy-preventive-medication
- The Menopause Society, 2022 Hormone Therapy Position Statement https://menopause.org/wp-content/uploads/press-release/ht-position-statement-release.pdf
- The Menopause Society, Ongoing Individualized Hormone Therapy Appears to Have No Age Limit https://menopause.org/press-releases/ongoing-individualized-hormone-therapy-appears-to-have-no-age-limit